Front Row Advisors’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $31.5K | Hold |
439
| – | – | 0.01% | 271 |
|
|
2025
Q4 | $34.8K | Hold |
439
| – | – | 0.01% | 248 |
|
|
2025
Q3 | $33.1K | Sell |
439
-17
| -4% | -$1.17K | 0.01% | 250 |
|
|
2025
Q2 | $31.5K | Buy |
456
+371
| +436% | +$24.3K | 0.01% | 248 |
|
|
2025
Q1 | $5.75K | Hold |
85
| – | – | ﹤0.01% | 404 |
|
|
2024
Q4 | $3.81K | Hold |
85
| – | – | ﹤0.01% | 419 |
|
|
2024
Q3 | $5.34K | Sell |
85
-270
| -76% | -$15.8K | ﹤0.01% | 407 |
|
|
2024
Q2 | $21K | Hold |
355
| – | – | 0.01% | 416 |
|
|
2024
Q1 | $28.3K | Buy |
355
+150
| +73% | +$11.5K | 0.01% | 334 |
|
|
2023
Q4 | $16.2K | Sell |
205
-150
| -42% | -$10.7K | 0.01% | 277 |
|
|
2023
Q3 | $24.8K | Sell |
355
-247
| -41% | -$17.5K | 0.01% | 335 |
|
|
2023
Q2 | $42K | Sell |
602
-3
| -0.5% | -$213 | 0.02% | 257 |
|
|
2023
Q1 | $45K | Sell |
605
-2
| -0.3% | -$168 | 0.02% | 254 |
|
|
2022
Q4 | $57K | Sell |
607
-4
| -0.7% | -$386 | 0.03% | 227 |
|
|
2022
Q3 | $58K | Buy |
611
+33
| +6% | +$3.27K | 0.03% | 227 |
|
|
2022
Q2 | $54K | Buy |
578
+17
| +3% | +$1.66K | 0.03% | 243 |
|
|
2022
Q1 | $57K | Sell |
561
-9
| -2% | -$945 | 0.02% | 246 |
|
|
2021
Q4 | $59K | Buy |
570
+205
| +56% | +$18.9K | 0.02% | 251 |
|
|
2021
Q3 | $31K | Hold |
365
| – | – | 0.01% | 326 |
|
|
2021
Q2 | $31K | Buy |
365
+33
| +10% | +$2.7K | 0.01% | 333 |
|
|
2021
Q1 | $25K | Hold |
332
| – | – | 0.01% | 367 |
|
|
2020
Q4 | $23K | Hold |
332
| – | – | 0.01% | 359 |
|
|
2020
Q3 | $23K | Buy |
332
+125
| +60% | +$7.78K | 0.01% | 353 |
|
|
2020
Q2 | $13K | Hold |
207
| – | – | 0.01% | 415 |
|
|
2020
Q1 | $13K | Sell |
207
-111
| -35% | -$7.41K | 0.01% | 407 |
|
|
2019
Q4 | $24K | Sell |
318
-2
| -0.6% | -$140 | 0.02% | 300 |
|
|
2019
Q3 | $20K | Sell |
320
-33
| -9% | -$1.96K | 0.01% | 324 |
|
|
2019
Q2 | $19K | Hold |
353
| – | – | 0.01% | 327 |
|
|
2019
Q1 | $19K | Sell |
353
-73
| -17% | -$4.51K | 0.01% | 328 |
|
|
2018
Q4 | $28K | Buy |
426
+38
| +10% | +$2.84K | 0.02% | 248 |
|
|
2018
Q3 | $27 | Sell |
388
-1,013
| -72% | -$72.4K | 0.02% | 264 |
|
|
2018
Q2 | $92 | Buy |
1,401
+1,085
| +343% | +$71.5K | 0.06% | 162 |
|
|
2018
Q1 | $20K | Buy |
316
+68
| +27% | +$4.88K | 0.01% | 329 |
|
|
2017
Q4 | $18K | Buy |
+248
| New | +$18K | 0.01% | 350 |
|
Other funds holding CVS
VCM
VPM
Front Row Advisors's CVS Position: Q1 2026 in Review
Front Row Advisors held its CVS Health (CVS) position steady in Q1 2026 at 439 shares worth $31.5K. The position accounts for 0.01% of the portfolio, ranked #271.
Front Row Advisors first reported a position in CVS in Q4 2017 and has held it in 34 quarters since. The position peaked at $59K in Q4 2021. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.
- Front Row Advisors held 439 shares of CVS Health worth $31.5K as of Q1 2026.
- Front Row Advisors left its CVS Health share count unchanged in Q1 2026.
- CVS Health made up 0.01% of Front Row Advisors's portfolio in Q1 2026, its #271 holding.
- Front Row Advisors first reported a position in CVS Health in Q4 2017 and has held it in 34 quarters since.
- Front Row Advisors's CVS Health position peaked at $59K in Q4 2021.
- 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.
Based on Front Row Advisors's 13F filing for Q1 2026, filed 19 May 2026.